Phoenix Biotech Acquisition Corp. Shares Halted, News Pending
Portfolio Pulse from Benzinga Newsdesk
Shares of Phoenix Biotech Acquisition Corp. (PBAX) have been halted due to pending news, with no further details provided.

June 05, 2023 | 11:56 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
PBAX shares halted due to pending news, causing uncertainty in the short term.
Shares of Phoenix Biotech Acquisition Corp. (PBAX) have been halted due to pending news. This creates uncertainty in the short term as investors await further information. The impact on the stock price is neutral until more details are provided.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100